RefluxStop implant shows promising efficacy in GERD management

A three-year prospective study on the RefluxStop implant for gastroesophageal reflux disease (GERD) revealed outstanding outcomes. Among 47 patients, there were no device-related adverse events or need for proton pump inhibitors post-treatment. The median GERD-HRQL score improved by 93.1%, while daily regurgitation decreased by 97.9%. Additionally, incidences of bothersome dysphagia dropped significantly, with complete resolution of baseline odynophagia. These results affirm the safety and effectiveness of RefluxStop in restoring normal gastroesophageal junction function.